Crosstalk-eliminated quantitative determination of aflatoxin B1-induced hepatocellular cancer stem cells based on concurrent monitoring of CD133, CD44, and aldehyde dehydrogenase1
A. Crosstalk-free high-content detection of CD133, CD44, and
-iv - Tables   Table 1. Absorbance of aflatoxin B1-8,9 epoxide-DNAadducts Furthermore, it has been reported that airborne exposure to mycotoxin contaminated dust and fungal components causes several magnitude toxic effect than oral exposure in experimental mice [4, 5] . Aflatoxin B1 has been shown to be the most potent natural carcinogen, as the main aflatoxin produced by toxigenic strains [6] . [7, 8] . Predominant mutation caused by exposure to aflatoxin B1 has been found to exhibit G to T transversion through numerous in vitro and in vivo models. The formed aflatoxin B1-8,9-epoxide-DNA adducts lead to the mutation of proto-oncogene and tumor suppressor genes, and induce HCC when the mutation is not repaired properly by DNA repair enzymes [9] . and prognosis of cancer [18] [19] [20] . Qdots possess excellent physical properties, such as high sensitivity and strong photostability as imaging nanoprobes [21] . In addition, Qdot values were plotted as a bar graph in Figure 4 (e). Compared to the control, the increase of aflatoxin B1-induced CSC ratio was determined to be 1.13%, 1.63%, and 3.03%, at 5 μM, 10 μM, and 20 μM, respectively (Table 2 ).
List of
-25 - CD133 is known to have a characteristic to decrease its expression level with tumor cell differentiation. This property causes CD133 to be a specific marker that isolates and identifies CSCs. Recently, it has been reported that CD133
silencing inhibits stemness properties and improves sensitivity to chemotherapeutic agents in CD133-positive liver CSCs [25, 26] . CD44 is a receptor for hyaluronic acid and involved in interaction between cells. CD44 also plays a role in cell migration based on interactions with ligands, such as collagens and matrix metalloproteinase. Moreover, CD44 has been reported as a cell surface marker for breast, prostate, and hepatocellular CSCs [27] [28] [29] . In addition to CD133 and CD44, ALDH1 is utilized to identify hepatocellular CSCs [30] . 
